CLN3 Gene Ceroid lipofuscinosis neuronal type 3 Genetic Test
Welcome to DNA Labs UAE, where we offer the CLN3 Gene Ceroid lipofuscinosis neuronal type 3 Genetic Test. This test is designed to detect mutations or variations in the CLN3 gene, which is associated with a rare genetic disorder called ceroid lipofuscinosis neuronal type 3 (CLN3-NCL), also known as juvenile Batten disease.
Test Details
The CLN3 gene is primarily associated with the nervous system and typically affects individuals in childhood or adolescence. Our NGS (Next-Generation Sequencing) genetic testing method allows us to analyze multiple genes simultaneously, providing comprehensive results for diagnosis, genetic counseling, and potentially predicting disease progression and response to treatment.
Components and Price
Our CLN3 Gene Ceroid lipofuscinosis neuronal type 3 Genetic Test is priced at 4400.0 AED. The test can be performed using a blood or saliva sample, or by using one drop of blood on an FTA Card.
Report Delivery
Once the sample is received, the report will be delivered within 3 to 4 weeks.
Test Type and Department
The CLN3 Gene Ceroid lipofuscinosis neuronal type 3 Genetic Test falls under the category of Metabolic Disorders. It is conducted in our Genetics department.
Pre Test Information
Prior to the test, it is important to provide the clinical history of the patient who is undergoing the CLN3 Gene Ceroid lipofuscinosis neuronal type 3 NGS Genetic DNA Test. A Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by Ceroid lipofuscinosis neuronal type 3.
Prenatal Testing and Referral
NGS genetic testing can also be used for prenatal testing in families with a known CLN3-NCL mutation. However, it is important to note that NGS genetic testing may not be available in all healthcare settings and may require a referral to a specialized genetic testing laboratory.
Expert Interpretation and Counseling
It is crucial to have the genetic test results interpreted by a qualified healthcare professional or genetic counselor who can provide appropriate counseling and guidance based on the individual’s specific situation.
At DNA Labs UAE, we strive to provide accurate and reliable genetic testing services. If you have any further questions or would like to schedule an appointment for the CLN3 Gene Ceroid lipofuscinosis neuronal type 3 Genetic Test, please contact us.
| Test Name | CLN3 Gene Ceroid lipofuscinosis neuronal type 3 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CLN3 Gene Ceroid lipofuscinosis neuronal type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Ceroid lipofuscinosis neuronal type 3 |
| Test Details |
The CLN3 gene is associated with a rare genetic disorder called ceroid lipofuscinosis neuronal type 3 (CLN3-NCL), also known as juvenile Batten disease. This disorder primarily affects the nervous system and typically begins in childhood or adolescence. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that can analyze multiple genes simultaneously. In the context of CLN3-NCL, NGS genetic testing can be used to detect mutations or variations in the CLN3 gene. This can help in diagnosing individuals with CLN3-NCL and identifying carriers of the disease. NGS genetic testing involves sequencing the DNA of an individual to identify any changes or mutations in the CLN3 gene. This can be done using a blood or saliva sample. The DNA is then analyzed using advanced sequencing technologies to detect any genetic variations. By identifying mutations in the CLN3 gene, NGS genetic testing can provide valuable information for diagnosis, genetic counseling, and potentially for predicting disease progression and response to treatment. It can also be used for prenatal testing in families with a known CLN3-NCL mutation. It is important to note that NGS genetic testing may not be available in all healthcare settings and may require a referral to a specialized genetic testing laboratory. Additionally, the interpretation of genetic test results should be done by a qualified healthcare professional or genetic counselor who can provide appropriate counseling and guidance based on the individual’s specific situation. |
